These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15908652)
21. Acute Lymphoblastic Leukemia with Central Nervous System Involvement-Challenges in Management. Suryaprakash S; Inaba H Indian J Pediatr; 2024 Jan; 91(1):59-66. PubMed ID: 37507619 [TBL] [Abstract][Full Text] [Related]
22. Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia. Shimony S; DeAngelo DJ; Luskin MR Blood Adv; 2024 Jan; 8(1):23-36. PubMed ID: 37389830 [TBL] [Abstract][Full Text] [Related]
23. An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia. Patel J; Gao X; Wang H Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108359 [TBL] [Abstract][Full Text] [Related]
24. Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases. Fukuta T; Tanaka T; Hashimoto T; Isahaya K; Kubo Y; Yamano Y; Satomi K; Hiraoka N; Shirakawa N; Arakawa A; Ogawa C; Nishimura N; Aoki J; Ito A; Inamoto Y; Kim SW; Fukuda T Int J Hematol; 2023 Jun; 117(6):933-940. PubMed ID: 36705847 [TBL] [Abstract][Full Text] [Related]
25. Carbohydrate-based drugs launched during 2000 Cao X; Du X; Jiao H; An Q; Chen R; Fang P; Wang J; Yu B Acta Pharm Sin B; 2022 Oct; 12(10):3783-3821. PubMed ID: 36213536 [TBL] [Abstract][Full Text] [Related]
26. Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response. Kamath A; Srinivasamurthy SK; Chowta MN; Ullal SD; Daali Y; Chakradhara Rao US Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015138 [TBL] [Abstract][Full Text] [Related]
27. Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective. Ali SS; Raj R; Kaur T; Weadick B; Nayak D; No M; Protos J; Odom H; Desai K; Persaud AK; Wang J; Govindarajan R Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804885 [TBL] [Abstract][Full Text] [Related]
28. A Review of Acute and Long-Term Neurological Complications Following Haematopoietic Stem Cell Transplant for Paediatric Acute Lymphoblastic Leukaemia. Gabriel M; Hoeben BAW; Uhlving HH; Zajac-Spychala O; Lawitschka A; Bresters D; Ifversen M Front Pediatr; 2021; 9():774853. PubMed ID: 35004543 [TBL] [Abstract][Full Text] [Related]
33. The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects. Fattizzo B; Rosa J; Giannotta JA; Baldini L; Fracchiolla NS Front Oncol; 2020; 10():273. PubMed ID: 32185137 [TBL] [Abstract][Full Text] [Related]
34. Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia. Follini E; Marchesini M; Roti G Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226848 [TBL] [Abstract][Full Text] [Related]
35. Relapsed T Cell ALL: Current Approaches and New Directions. McMahon CM; Luger SM Curr Hematol Malig Rep; 2019 Apr; 14(2):83-93. PubMed ID: 30880359 [TBL] [Abstract][Full Text] [Related]
36. Advances in the understanding and management of T-cell prolymphocytic leukemia. Laribi K; Lemaire P; Sandrini J; Baugier de Materre A Oncotarget; 2017 Nov; 8(61):104664-104686. PubMed ID: 29262669 [TBL] [Abstract][Full Text] [Related]
37. Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma. Kadia TM; Gandhi V Expert Rev Hematol; 2017 Jan; 10(1):1-8. PubMed ID: 27869523 [TBL] [Abstract][Full Text] [Related]
38. Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future. Sorge CE; McDaniel JK; Xavier AC Pharmaceuticals (Basel); 2016 May; 9(2):. PubMed ID: 27213405 [TBL] [Abstract][Full Text] [Related]
39. Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial Efficiency. Yeh JC; Huang P; Cohen KJ J Pediatr Hematol Oncol; 2016 Jul; 38(5):360-6. PubMed ID: 27164535 [TBL] [Abstract][Full Text] [Related]
40. Improving outcomes in childhood T-cell acute lymphoblastic leukemia: promising results from the Children's Oncology Group incorporating nelarabine into front-line therapy. Muffly L; Larson RA Transl Pediatr; 2012 Oct; 1(2):120-2. PubMed ID: 26835275 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]